Dopamine agonist‐induced antecollis in Parkinson's disease
Identifieur interne : 002348 ( Main/Exploration ); précédent : 002347; suivant : 002349Dopamine agonist‐induced antecollis in Parkinson's disease
Auteurs : Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Shigeyuki Kojima [Japon] ; Satsuki Mitsuma [Japon] ; Yukari Sekiguchi [Japon] ; Toshihide Kanesaka [Japon] ; Satoshi Kuwabara [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-12-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Adult, Aged, Dopamine Agonists (adverse effects), Dopamine Agonists (therapeutic use), Dopamine agonist, Dyskinesia, Drug-Induced (etiology), Dyskinesia, Drug-Induced (pathology), Female, Head, Humans, Middle Aged, Neck Muscles (physiopathology), Nervous system diseases, Parkinson Disease (drug therapy), Parkinson disease, Parkinson's disease, Pergolide, Pramipexole, antecollis, dopamine agonist, dropped head syndrome, pergolide, pramipexole.
- MESH :
- chemical , adverse effects : Dopamine Agonists.
- chemical , therapeutic use : Dopamine Agonists.
- drug therapy : Parkinson Disease.
- etiology : Dyskinesia, Drug-Induced.
- pathology : Dyskinesia, Drug-Induced.
- physiopathology : Neck Muscles.
- Adult, Aged, Female, Humans, Middle Aged.
Abstract
Few cases of dopamine agonist‐induced antecollis in Parkinson's disease (PD) have been reported. Literature review of 16 PD patients including our 3 cases with dopamine agonist‐induced antecollis showed predominance of (1) Japanese, (2) women, and (3) Hoehn‐Yahr stage of ≥3. We experienced three Japanese PD patients who subacutely exhibited antecollis following increased dopamine agonist dose that improved just after withdrawal of the agonist. One patient developed antecollis during increasing pramipexole dose in combination with cabergoline. Antecollis in another patient appeared during increasing pramipexole dose; it worsened after substituting pergolide for pramipexole, but improved after withdrawal of pergolide. Our cases indicate that there is no specific dopamine agonist causing antecollis, and it is possibly caused by a number of single dopamine agonists or a combination of them. Dopamine agonist‐induced antecollis should be considered when encountering antecollis in PD patients being treated with dopamine agonists and withdrawal of the agonist can improve symptoms. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22779
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000C32
- to stream Istex, to step Curation: 000C32
- to stream Istex, to step Checkpoint: 000F50
- to stream PubMed, to step Corpus: 001B10
- to stream PubMed, to step Curation: 001B10
- to stream PubMed, to step Checkpoint: 001E52
- to stream Ncbi, to step Merge: 002873
- to stream Ncbi, to step Curation: 002873
- to stream Ncbi, to step Checkpoint: 002873
- to stream Main, to step Merge: 002C09
- to stream PascalFrancis, to step Corpus: 000C56
- to stream PascalFrancis, to step Curation: 002063
- to stream PascalFrancis, to step Checkpoint: 000F09
- to stream Main, to step Merge: 003006
- to stream Main, to step Curation: 002348
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine agonist‐induced antecollis in Parkinson's disease</title><author><name sortKey="Uzawa, Akiyuki" sort="Uzawa, Akiyuki" uniqKey="Uzawa A" first="Akiyuki" last="Uzawa">Akiyuki Uzawa</name></author><author><name sortKey="Mori, Masahiro" sort="Mori, Masahiro" uniqKey="Mori M" first="Masahiro" last="Mori">Masahiro Mori</name></author><author><name sortKey="Kojima, Shigeyuki" sort="Kojima, Shigeyuki" uniqKey="Kojima S" first="Shigeyuki" last="Kojima">Shigeyuki Kojima</name></author><author><name sortKey="Mitsuma, Satsuki" sort="Mitsuma, Satsuki" uniqKey="Mitsuma S" first="Satsuki" last="Mitsuma">Satsuki Mitsuma</name></author><author><name sortKey="Sekiguchi, Yukari" sort="Sekiguchi, Yukari" uniqKey="Sekiguchi Y" first="Yukari" last="Sekiguchi">Yukari Sekiguchi</name></author><author><name sortKey="Kanesaka, Toshihide" sort="Kanesaka, Toshihide" uniqKey="Kanesaka T" first="Toshihide" last="Kanesaka">Toshihide Kanesaka</name></author><author><name sortKey="Kuwabara, Satoshi" sort="Kuwabara, Satoshi" uniqKey="Kuwabara S" first="Satoshi" last="Kuwabara">Satoshi Kuwabara</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0A8B9E2146E74D21F038EA0150457374F4105C53</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22779</idno><idno type="url">https://api.istex.fr/document/0A8B9E2146E74D21F038EA0150457374F4105C53/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000C32</idno><idno type="wicri:Area/Istex/Curation">000C32</idno><idno type="wicri:Area/Istex/Checkpoint">000F50</idno><idno type="wicri:doubleKey">0885-3185:2009:Uzawa A:dopamine:agonist:induced</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:19890970</idno><idno type="wicri:Area/PubMed/Corpus">001B10</idno><idno type="wicri:Area/PubMed/Curation">001B10</idno><idno type="wicri:Area/PubMed/Checkpoint">001E52</idno><idno type="wicri:Area/Ncbi/Merge">002873</idno><idno type="wicri:Area/Ncbi/Curation">002873</idno><idno type="wicri:Area/Ncbi/Checkpoint">002873</idno><idno type="wicri:Area/Main/Merge">002C09</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:10-0071271</idno><idno type="wicri:Area/PascalFrancis/Corpus">000C56</idno><idno type="wicri:Area/PascalFrancis/Curation">002063</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000F09</idno><idno type="wicri:doubleKey">0885-3185:2009:Uzawa A:dopamine:agonist:induced</idno><idno type="wicri:Area/Main/Merge">003006</idno><idno type="wicri:Area/Main/Curation">002348</idno><idno type="wicri:Area/Main/Exploration">002348</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopamine agonist‐induced antecollis in Parkinson's disease</title><author><name sortKey="Uzawa, Akiyuki" sort="Uzawa, Akiyuki" uniqKey="Uzawa A" first="Akiyuki" last="Uzawa">Akiyuki Uzawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Matsudo Municipal Hospital, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author><author><name sortKey="Mori, Masahiro" sort="Mori, Masahiro" uniqKey="Mori M" first="Masahiro" last="Mori">Masahiro Mori</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author><author><name sortKey="Kojima, Shigeyuki" sort="Kojima, Shigeyuki" uniqKey="Kojima S" first="Shigeyuki" last="Kojima">Shigeyuki Kojima</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Matsudo Municipal Hospital, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author><author><name sortKey="Mitsuma, Satsuki" sort="Mitsuma, Satsuki" uniqKey="Mitsuma S" first="Satsuki" last="Mitsuma">Satsuki Mitsuma</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author><author><name sortKey="Sekiguchi, Yukari" sort="Sekiguchi, Yukari" uniqKey="Sekiguchi Y" first="Yukari" last="Sekiguchi">Yukari Sekiguchi</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Matsudo Municipal Hospital, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author><author><name sortKey="Kanesaka, Toshihide" sort="Kanesaka, Toshihide" uniqKey="Kanesaka T" first="Toshihide" last="Kanesaka">Toshihide Kanesaka</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Matsudo Municipal Hospital, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author><author><name sortKey="Kuwabara, Satoshi" sort="Kuwabara, Satoshi" uniqKey="Kuwabara S" first="Satoshi" last="Kuwabara">Satoshi Kuwabara</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Graduate School of Medicine, Chiba University, Chiba</wicri:regionArea><wicri:noRegion>Chiba</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-12-15">2009-12-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">16</biblScope><biblScope unit="page" from="2408">2408</biblScope><biblScope unit="page" to="2411">2411</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">0A8B9E2146E74D21F038EA0150457374F4105C53</idno><idno type="DOI">10.1002/mds.22779</idno><idno type="ArticleID">MDS22779</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Dopamine Agonists (adverse effects)</term><term>Dopamine Agonists (therapeutic use)</term><term>Dopamine agonist</term><term>Dyskinesia, Drug-Induced (etiology)</term><term>Dyskinesia, Drug-Induced (pathology)</term><term>Female</term><term>Head</term><term>Humans</term><term>Middle Aged</term><term>Neck Muscles (physiopathology)</term><term>Nervous system diseases</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Pergolide</term><term>Pramipexole</term><term>antecollis</term><term>dopamine agonist</term><term>dropped head syndrome</term><term>pergolide</term><term>pramipexole</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Agonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Agonists</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Neck Muscles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Middle Aged</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Pergolide</term><term>Pramipexole</term><term>Stimulant dopaminergique</term><term>Tête</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Few cases of dopamine agonist‐induced antecollis in Parkinson's disease (PD) have been reported. Literature review of 16 PD patients including our 3 cases with dopamine agonist‐induced antecollis showed predominance of (1) Japanese, (2) women, and (3) Hoehn‐Yahr stage of ≥3. We experienced three Japanese PD patients who subacutely exhibited antecollis following increased dopamine agonist dose that improved just after withdrawal of the agonist. One patient developed antecollis during increasing pramipexole dose in combination with cabergoline. Antecollis in another patient appeared during increasing pramipexole dose; it worsened after substituting pergolide for pramipexole, but improved after withdrawal of pergolide. Our cases indicate that there is no specific dopamine agonist causing antecollis, and it is possibly caused by a number of single dopamine agonists or a combination of them. Dopamine agonist‐induced antecollis should be considered when encountering antecollis in PD patients being treated with dopamine agonists and withdrawal of the agonist can improve symptoms. © 2009 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Uzawa, Akiyuki" sort="Uzawa, Akiyuki" uniqKey="Uzawa A" first="Akiyuki" last="Uzawa">Akiyuki Uzawa</name></noRegion><name sortKey="Kanesaka, Toshihide" sort="Kanesaka, Toshihide" uniqKey="Kanesaka T" first="Toshihide" last="Kanesaka">Toshihide Kanesaka</name><name sortKey="Kojima, Shigeyuki" sort="Kojima, Shigeyuki" uniqKey="Kojima S" first="Shigeyuki" last="Kojima">Shigeyuki Kojima</name><name sortKey="Kuwabara, Satoshi" sort="Kuwabara, Satoshi" uniqKey="Kuwabara S" first="Satoshi" last="Kuwabara">Satoshi Kuwabara</name><name sortKey="Mitsuma, Satsuki" sort="Mitsuma, Satsuki" uniqKey="Mitsuma S" first="Satsuki" last="Mitsuma">Satsuki Mitsuma</name><name sortKey="Mori, Masahiro" sort="Mori, Masahiro" uniqKey="Mori M" first="Masahiro" last="Mori">Masahiro Mori</name><name sortKey="Sekiguchi, Yukari" sort="Sekiguchi, Yukari" uniqKey="Sekiguchi Y" first="Yukari" last="Sekiguchi">Yukari Sekiguchi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002348 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002348 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:0A8B9E2146E74D21F038EA0150457374F4105C53
|texte= Dopamine agonist‐induced antecollis in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |